GE HEALTHCARE invest $ 138 million in Cork, Ireland’s manufacturing facility to meet rising demand for contrast media

On By Littum

Ge Healthcare's Contrast Media Manufacturing Site in Cork (Photo: Business Wire)
Ge Healthcare’s Contrast Media Manufacturing Site in Cork (Photo: Business Wire)

  • New $ 138 million facility at GE Healthcare’s Cork Manufacturing Site will enable 25 million more patient doses of contrast media a year by the end of 2027I

  • Demand for CT and X-Ray Contrast Media used to improve medical imaging procedures globally is estimated to be doubled in the next ten yearsII

  • Investments create additional capacity to meet the growing demand while providing increased flexibility and resistance for delivery security

Chalfont st. Giles, England, 31 January 2025-((Business Wire) -Ge Healthcare (NASDAQ: Gehc) today announced a $ 138 million investment to expand his Carrigohill, Cork Contrast Media Fill and Finish Manufacturing Site in Ireland. A new advanced facility due to the existing location will enable 25 million more patient doses a year with contrast media by the end of 2027, which helps to meet the growing global demand.

Contrast media are injectable diagnostic imaging agents used to improve the visualization of organs, blood vessels and tissues during medical imaging. The global demand for iodine -based contrast media used in X -ray, computed tomography (CT) and intervention procedures is expected to double in the next decade, driven by aging populations and the rising global occurrence of chronic disorders. By 2024, the Carrigohill plant, along with GE Healthcare’s other fullness and finish production sites in Shanghai, China and Oslo, delivered over 100 million patient doses of contrast media around the world around the worldIII.

The new 3000m2 Facility – which supports both established and pipeline products – will include preparation vessels, multifunctional powder handling systems, a new filling line and autoclaves with advanced automation systems underlying production. Once established, the extra capacity will meet the growing global demand while providing increased flexibility and elasticity across GE Healthcare’s Contrast Media Production Network for Security of Supply.

President and CEO of GE Healthcare’s Pharmaceutical Diagnostics (PDX) -Sgment, Kevin O’Neill, said: “As an industry, we have a responsibility to help meet the growing global demand for contrast media from healthcare providers and their patients. This new facility shows our wider commitment not only to meet the future demand, but also to increase the elasticity and security of the industry’s supply to customers.

Eugene Barrett, place leader and CEO, GE Healthcare Ireland, said: “This expansion strengthens our long -standing presence in Cork, where we have a very skilled team, access to leading talent in the pharmaceutical industry, strong distribution link all over the world and one expected one Great partnership with Ida Ireland.